Jubilant Pharmova Receives ICRA AA+ Stable Rating for Rs 1,400 Crore NCDs
Jubilant Pharmova Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 10:01 pm
Jubilant Pharmova Receives ICRA AA+ Stable Rating for Rs 1,400 Crore NCDs ICRA Limited assigned an [ICRA]AA+ rating with a Stable outlook to Jubilant Pharmova Limited's proposed Non-Convertible Debenture (NCD) programme amounting to Rs 1,400.00 crore. The rating communication was received by the company on 13th Oct'26. The assigned credit rating remains valid throughout the life of the instrument once issued, reflecting strong creditworthiness for the company's planned debt issuance.
Original exchange filing (PDF)
More announcements from Jubilant Pharmova Ltd
- Investor Meet Outcome 路 16 Nov 2026
- Press Release 路 14 Nov 2026
- Un-audited Financial Results for the Quarter and Half Year ended September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Jubilant Pharmova Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Press Release 路 11 Nov 2026
- Allotment 路 06 Nov 2026
- Allotment of NCD 路 06 Nov 2026
